Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa. Treatment with intravenous immune globulin.

[1]  M. Pollack,et al.  Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans. , 1983, The Journal of infectious diseases.

[2]  J. Janda,et al.  Pseudomonas aeruginosa enzyme profiling: predictor of potential invasiveness and use as an epidemiological tool , 1981, Journal of clinical microbiology.

[3]  J. Lundblad,et al.  A New Preparation of Modified Immune Serum Globulin (Human) Suitable for Intravenous Administration , 1981, Vox sanguinis.

[4]  J. Lundblad,et al.  A New Preparation of Modified Immune Serum Globulin (Human) Suitable for Intravenous Administration , 1981, Vox sanguinis.

[5]  P. B. Fernandes,et al.  Demonstration of cell envelope-bound exotoxin A in Pseudomonas aeruginosa , 1980, Infection and immunity.

[6]  C. Haidaris,et al.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors. , 1979, Canadian journal of microbiology.

[7]  B. Wretlind,et al.  Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection , 1979, Infection and immunity.

[8]  I. A. Holder,et al.  Role of Exotoxin and Protease as Possible Virulence Factors in Experimental Infections with Pseudomonas aeruginosa , 1978, Infection and immunity.

[9]  S. Davis,et al.  Efficacy of modified human immune serum globulin in the treatment of experimental murine infections with seven immunotypes of Pseudomonas aeruginosa. , 1975, The Journal of infectious diseases.

[10]  I. A. Holder,et al.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. , 1975, The Journal of infectious diseases.

[11]  K. Morihara,et al.  Effects of protease and elastase from Pseudomonas aeruginosa on skin. , 1975, The Japanese journal of experimental medicine.

[12]  J. Wesley,et al.  Immunization against Pseudomonas in infection after thermal injury. , 1974, The Journal of infectious diseases.

[13]  K. Miller,et al.  Elastase of Pseudomonas aeruginosa: Inactivation of Complement Components and Complement-Derived Chemotactic and Phagocytic Factors , 1974, Infection and immunity.

[14]  P. Liu,et al.  Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A. , 1973, The Journal of infectious diseases.

[15]  H. C. Hopps,et al.  Staining of bacteria in tissue sections: a reliable gram stain method. , 1973, American journal of clinical pathology.

[16]  I. A. Holder,et al.  Burn wounds: microbiology, local host defenses, and current therapy. , 1973, CRC critical reviews in clinical laboratory sciences.

[17]  S. Saslaw,et al.  Effect of Vincristine Sulfate on Pseudomonas Infections in Monkeys , 1972, Infection and immunity.

[18]  O. Pavlovskis,et al.  Pseudomonas aeruginosa exotoxin: effect on cell cultures. , 1972, The Journal of infectious diseases.

[19]  I. A. Holder,et al.  Infected surface wound: an experimental model and a method for the quantitation of bacteria in infected tissues. , 1972, Applied microbiology.

[20]  I. A. Holder,et al.  Enhanced survival in burned mice treated with antiserum prepared against normal and burned skin. , 1971, The Journal of trauma.

[21]  B. Macmillan.  Ecology of bacteria colonizing the burned patient given topical and systemic gentamicin therapy: a five-year study. , 1971, The Journal of infectious diseases.

[22]  F. Kobayashi.  Experimental infection with Pseudomonas aeruginosa in mice. I. The virulence of Pseudomonas aeruginosa for mice. , 1971, Japanese journal of microbiology.

[23]  F. Kobayashi.  Experimental Infection with Pseudomonas aeruginosa in Mice , 1971 .

[24]  J. Alexander,et al.  Immunological Control of Pseudomonas Infection in Burn Patients: A Clinical Evaluation , 1971 .

[25]  W. Altemeier,et al.  Topical and systemic antibacterial agents in the treatment of burns. , 1970, Annals of surgery.

[26]  C. Janeway,et al.  Intravenous dissociated gamma globulin in control of hypogammaglobulinemia. , 1969, Vox sanguinis.

[27]  I. Feller,et al.  Pseudomonas vaccine and hyperimmune plasma for burned patients. , 1968, Archives of surgery.

[28]  M. García,et al.  The lethal events in experimental Pseudomonas aeruginosa infection of mice. , 1968, The Journal of infectious diseases.

[29]  A. Mason,et al.  Surface Infection with Pseudomonas Aeruginosa , 1964, Annals of surgery.

[30]  Ronald J. McRipley,et al.  Increased Susceptibility of Burned Rats to Pseudomonas aeruginosa∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[31]  P. Stastny,et al.  Role of infection in mortality from severe burns. Evaluation of plasma, gamma-globulin, albumin and saline-solution therapy in a group of Peruvian children. , 1962, The New England journal of medicine.

[32]  H. Isliker,et al.  Intravenous Administration of Human γ‐Globulin * , 1962 .

[33]  B. Holloway.  Genetic recombination in Pseudomonas aeruginosa. , 1955, Journal of general microbiology.

[34]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .